Article
Characterization of the tenofovir resistance-associated mutations in the hepatitis B virus isolates across genotypes A to D.
Antiviral research - 1 Jul 2022
Liu Tingting, Sun Qingsong, Gu Jiaqi, Cen Shan, Zhang Quan
Abstract excerpt
Tenofovir is wildly used to treat chronic hepatitis B (CHB) infection due to good potency and high genetic barrier to drug resistance. To date, it remains controversial whether hepatitis B virus (HBV) could be resistant to tenofovir. This study used multiple HBV isolates across genotypes A to D to characterize the reported tenofovir resistance-associated mutations identified from a few clinical case reports. Our...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
